A histological and histochemical analyses were carried out on the entire alimentary canal of the rainbow trout Oncorhynchus mykiss. In particular the oesophageal region showed presence of terminal b-D-galactose(1-3)-N-acetylgalactosamine and a-N-acetylgalactosamine. In the anterior and posterior regions of the stomach, lining epithelium and gastric pits exhibited the presence of b-gal and a-GalNAc. In addition sialoglycoconjugates having sialic acid-bgalactose(1-3)-N-acetylgalactosamine and sialic acid-N-acetylgalactosamine as terminal triand di-saccharides, were demonstrated. In proximal and distal intestine goblet cells showed the presence of sialoglyconjugates, having sialic acid-b-gal(1-3)-GalNAc and sialic acidGalNAc as terminal sequences, belonging to N-linked chains. In the enterocytes of the entire intestine, terminal GlcNAc, a-Gal, a-fucose were found. #

A histochemical study using conventional and lectin methods was performed on the stomach of fasting and feeding adults of Tilapia spp. A battery of HRP-conjugated lectins combined with exoglycosidase digestion was used. The differences found in the epithelium, gastric pits and gastric glands between fasting and feeding subjects were related to the functional stages of the organ. Carbohydrate composition was also compared with that of mammals and birds. 1996 The Fisheries Society of the British Isles

We have previously reported that prostaglandin F(2alpha) (PGF(2alpha)) and its selective agonist fluprostenol increase basic fibroblast growth factor (FGF-2) mRNA and protein production in osteoblastic Py1a cells. The present report extends our previous studies by showing that Py1a cells express FGF receptor-2 (FGFR2) and that treatment with PGF(2alpha) or fluprostenol decreases FGFR2 mRNA. We have used confocal and electron microscopy to show that, under PGF(2alpha) stimulation, FGF-2 and FGFR2 proteins accumulate near the nuclear envelope and colocalize in the nucleus of Py1a cells. Pre-treatment with cycloheximide blocks nuclear labelling for FGF-2 in response to PGF(2alpha). Treatment with SU5402 does not block prostaglandin-mediated nuclear internalization of FGF-2 or FGFR2. Various effectors have been used to investigate the signal transduction pathway. In particular, pre-treatment with phorbol 12-myristate 13-acetate (PMA) prevents the nuclear accumulation of FGF-2 and FGFR2 in response to PGF(2alpha). Similar results are obtained by pre-treatment with the protein kinase C (PKC) inhibitor H-7. In addition, cells treated with PGF(2alpha) exhibit increased nuclear labelling for the mitogen-activated protein kinase (MAPK), p44/ERK2. Pre-treatment with PMA blocks prostaglandin-induced ERK2 nuclear labelling, as confirmed by Western blot analysis. We conclude that PGF(2alpha) stimulates nuclear translocation of FGF-2 and FGFR2 by a PKC-dependent pathway; we also suggest an involvement of MAPK/ERK2 in this process.

The glycoconjugates secreted by the anterior and posterior intestinal segments of Tilapia spp. were characterized by means of both conventional histochemical procedures (PAS, AB, AB-PAS, LID, HID) and a battery of 12 horseradish peroxidase labelled lectins. Some sections were treated with glycolytic enzymes and KOH before conventional and lectin stainings. The large majority of the mucopolysaccharides secreted by the goblet cells of the anterior segment are carboxylated while only a few carry sulphate groups. The mucopolysaccharides in the anterior intestine contained chondroitin, heparin and chondroitinsulphates which can provide protection for intestinal mucosae. DBA lectin staining demonstrated the presence of some endocrine cells in the anterior segment. 1997 The Fisheries Society of the British Isles 1997 The Fisheries Society of the British Isles

In this study, we investigated the role of prostaglandin F2alpha (PGF2alpha) in mouse osteoblast survival and the function of fibroblast growth factor 2 (FGF-2) and fibroblast growth factor receptor 1 (FGFR1) in this process. In particular, for the first time, we demonstrated that PGF2alpha increased osteoblast survival in a dose-dependent manner and we showed that the effect is correlated with an increase in Bcl-2/Bax ratio. Furthermore, we demonstrated that PGF2alpha caused a decrement of the active caspases 9 and 3. By blocking FGF-2 with the specific neutralizing antibody and by depletion of FGFR1 gene with a specific siRNA, we showed that FGFR1 and FGF-2 are critical for the increment of Bcl-2/Bax ratio and the decrement of the active caspases 9 and 3, induced by PGF2alpha. Moreover, transmission electron microscopy studies showed that PGF2alpha increased binding of FGF-2 and FGFR1 and co-localization of reactive sites at plasma membrane level. In conclusion, we report a novel mechanism in which PGF2alpha induces FGF-2 binding to its specific cell surface receptor 1 leading to a cascade pathway that culminates with increased mouse osteoblast survival.